Your browser doesn't support javascript.
loading
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Sørensen, Anders Lindholm; Mikkelsen, Stine Ulrik; Knudsen, Trine Alma; Bjørn, Mads Emil; Andersen, Christen Lykkegaard; Bjerrum, Ole Weis; Brochmann, Nana; Patel, Dustin Andersen; Gjerdrum, Lise Mette Rahbek; El Fassi, Daniel; Kruse, Torben A; Larsen, Thomas Stauffer; Mourits-Andersen, Hans Torben; Nielsen, Claus Henrik; Ellervik, Christina; Pallisgaard, Niels; Thomassen, Mads; Kjær, Lasse; Skov, Vibe; Hasselbalch, Hans Carl.
Afiliación
  • Sørensen AL; Department of Hematology, Zealand University Hospital, Roskilde, Denmark; Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. anderslindholmsorensen@hotmail.com.
  • Mikkelsen SU; Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark.
  • Knudsen TA; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Bjørn ME; Herlev University Hospital, Copenhagen, Denmark.
  • Andersen CL; Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Public Health, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bjerrum OW; Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Brochmann N; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Patel DA; Department of Hematology, Zealand University Hospital, Roskilde, Denmark; Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Gjerdrum LMR; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • El Fassi D; Herlev University Hospital, Copenhagen, Denmark.
  • Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  • Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Mourits-Andersen HT; Department of Hematology, South-West Jutlandic Hospital, Esbjerg, Denmark.
  • Nielsen CH; Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Ellervik C; Herlev University Hospital, Copenhagen, Denmark; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Data and Development Support, Region Zealand, Sorø, Denmark.
  • Pallisgaard N; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  • Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
Haematologica ; 105(9): 2262-2272, 2020 09 01.
Article en En | MEDLINE | ID: mdl-33054051
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca